Biotronik has announced the availability of the Edora line of devices, the company’s first available pacemaker series featuring the company’s magnetic resonance imaging (MRI) AutoDetect technology.
Edora SR-T is the smallest MR-conditional pacemaker with automated MRI detection capability available in the USA, with a volume of 10cc and weight of 20.8g. The lifespan of Edora devices can exceed 13 years.
The Edora series with MRI AutoDetect is designed to minimise programming burdens while ensuring patient safety during MR imaging. MRI AutoDetect is engineered to automatically recognise when a patient enters an MRI field, and to convert the device to MRI mode. The device then returns to its permanent program following the completion of the scan.
“MR conditional devices have impacted patient care significantly, but they create complexities for healthcare providers. Aligning clinical schedules to ensure devices are programmed at the right time is a real logistical challenge,” says Rod Passman, professor of Medicine at Northwestern University in Chicago, USA. “MRI AutoDetect helps overcome this by significantly shortening the window of reduced therapy and eliminating the need for post-scan reprogramming appointments. This means improved patient safety and increased operational efficiency, which ultimately translates to better patient care.”
Edora pacemakers also feature Biotronik Home Monitoring and Closed Loop Stimulation (CLS).
